Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial. [electronic resource]
Producer: 20140716Description: 1693-703 p. digitalISSN:- 1875-8312
- Acute Coronary Syndrome -- diagnosis
- Cardiovascular Agents -- administration & dosage
- Coated Materials, Biocompatible
- Coronary Circulation
- Coronary Vessels -- diagnostic imaging
- Drug-Eluting Stents
- Echocardiography, Doppler, Color
- Echocardiography, Doppler, Pulsed
- Everolimus
- Humans
- Hyperplasia
- Neointima
- Percutaneous Coronary Intervention -- adverse effects
- Predictive Value of Tests
- Prospective Studies
- Prosthesis Design
- Single-Blind Method
- Sirolimus -- administration & dosage
- Stents
- Time Factors
- Titanium
- Tomography, Optical Coherence
- Treatment Outcome
- Vasodilation
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.